Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA).

Bibliographic Details
Title: Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA).
Authors: Manne, Ashish, Sheel, Ankur, Sara, Amir, Noonan, Anne M., Yu, Lianbo, Yang, Wancai, Hays, John L., Mittra, Arjun, Malalur, Pannaga G., Rahman, Shafia, Roychowdhury, Sameek, Elkatib, Rifat, Jin, Ning, Cloyd, Jordan M., Dillhoff, Mary, Ejaz, Aslam, Esnakula, Ashwini K.
Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p690-690, 117p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.2024.42.3_suppl.690
Published in:Journal of Clinical Oncology
Language:English